Jasper Ridge Partners’s Verona Pharma VRNA Stock Holding History

Jasper Ridge Partners’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,635	Closed	-$1.13M	–	147
2025 Q3	$1.13M	Hold	10,635	–	–	0.03%	90
2025 Q2	$1.01M	Hold	10,635	–	–	0.03%	89
2025 Q1	$675K	Buy	+10,635	New	+$636K	0.02%	93

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Jasper Ridge Partners's VRNA Position: Q4 2025 in Review

Jasper Ridge Partners sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 10,635 shares — an estimated $1.13M sold.

Jasper Ridge Partners first reported a position in VRNA in Q1 2025 and held it in 3 quarters. The position peaked at $1.13M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Jasper Ridge Partners reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Jasper Ridge Partners sold 10,635 Verona Pharma shares in Q4 2025, an estimated $1.13M.
Jasper Ridge Partners first reported a position in Verona Pharma in Q1 2025 and held it in 3 quarters.
Jasper Ridge Partners's Verona Pharma position peaked at $1.13M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Jasper Ridge Partners's 13F filing for Q4 2025, filed 12 Feb 2026.